Denosumab is a human monoclonal immunoglobulin G2 (IgG2) antibody that is used in the management of osteoporosis and various bone-related disorders to help strengthen bones and prevent fractures. Declining renal function and the drug denosumab are both associated with an increased risk of hypocalcaemia. The combination of both factors in a patient, along with the long half-life of the drug, can cause further exacerbation of this risk.
View Article and Find Full Text PDFMulti-drug resistance (MDR) in continues to pose a significant public health challenge, particularly in developing countries. Recent advances in genomics strengthen the surveillance of MDR-pathogens and antimicrobial resistance (AMR) mediators. However, genome-based investigations into resistome dynamics in are limited, specifically in Bangladesh.
View Article and Find Full Text PDFPrecipitation polymerization method was used to synthesize chitosan based poly[chitosan-N-isopropylmethacrylamide-acrylic acid] [P(CS-NI-AA)] microgel particles. Synthesized P(CS-NI-AA) microgel particles were utilized as micro-reactors for the fabrication of silver nanoparticles (AgNPs) inside the structure of microgels through chemical reduction of Ag ions using NaBH as reducing agent. P(CS-NI-AA) and Ag-P(CS-NI-AA) systems were analyzed using various characterization techniques like scanning electron microscopy (SEM), ultraviolet-visible (UV-visible) spectroscopy, transmission electron microscopy (TEM), X-ray diffraction (XRD) and Fourier transform infrared (FTIR) spectroscopy.
View Article and Find Full Text PDF